johnmartinhg-blog - Tumblr blog

[johnmartinhg-blog]

Organic Shrimp Market is expected to grow at a CAGR of 7.7% by 2027

[johnmartinhg-blog]

8.2% CAGR for Food Allergen Testing Market from 2019 to 2027 - The Insig...

[johnmartinhg-blog]

The Insight Partners - Leading Market Research Provider

[johnmartinhg-blog]

IoT in Healthcare Market to Grow at a CAGR of 21.2% Through 2025

According to the new research report published by The Insight Partners, titled “IoT in Healthcare Market - Global Analysis and Forecast to 2025”, the global IoT in healthcare market is expected to reach US$ 135.9 Bn in 2025, registering a CAGR of 21.2% during the forecast period 2017-2025.

In 2025, North America is expected to account for more than one-third of total IoT in healthcare revenue market share. The growth is majorly driven by enhanced IoT infrastructure in the region with better connectivity, availability of skilled professionals and rising incidences of chronic diseases such as obesity, diabetes etc.

Get PDF Sample Copy of this Report @ https://bit.ly/2ysjfNB

Top Dominating Key Players:

Koninklijke Philips N.V.

Medtronic Plc

Siemen Healthcare GmbH

Proteus Digital Health, Inc.

IBM Watson Health

General Electric Healthcare

Microsoft Corporation

Qualcomm Life, Inc.

STANLEY Healthcare

Verily Life Sciences LLC (Alphabet-Google)

The IoT in Healthcare market is experiencing a high growth and adoption rate from past few years and is also expected to experience a significant growth and adoption rate in years to come. One of the major reason for high adoption of IoT in Healthcare is the need to decrease costs related to healthcare facilities worldwide. Developing economies with high growth in population and decreasing prices for internet services are providing opportunities for the players operating in the global IoT in Healthcare market. Few of the player that are operating successfully in global IoT in Healthcare market are Koninklijke Philips N.V., GE Healthcare, IBM Corp., Microsoft Corporation and others.

Few of the factors that might act as a hindrance in the growth of the IoT in Healthcare market are high costs associated to smart devices and IoT infrastructure, and security and privacy concerns related to theft of highly confidential and sensitive health data of the patients.

Technology up gradation, government initiatives to deploy IoT solutions in healthcare industry, rising incidences of chronic diseases, and continuously increasing adoption of smart devices are some of the key driving factors for this market. Many healthcare institutions and providers are adopting IoT in healthcare solutions to deliver better care to their patients and optimize their clinical workflow. The global IoT in Healthcare market is broadly classified into solution (medical systems & devices and software solutions & tools), services (professional services & integration services) application (medication management, patient monitoring, fitness & wellness measurement, clinical workflow management and others) and end-user (patients & individuals, diagnostic & research and labs, hospitals & healthcare institutes and government authority); and geography.

Reasons to Buy the Report :

Learn about the driving factors, affecting the market growth.

Imbibe the advancements and progress in the market during the forecast period.

Understand where the market opportunities lies.

Compare and evaluate various options affecting the market.

Pick up on the leading market players within the market.

Envision the restrictions and restrains that are likely to hamper the market.

[johnmartinhg-blog]

Biodefense Market Trends Estimates High Demand By 2027

According to The Insight Partners market research study of ‘Biodefense Market to 2027  – Global Analysis and Forecasts by Product.’ The global Biodefense market is expected to reach US$ 8,350.74 Mn in 2027 from US$ 4,108.24 Mn in 2019. The market is estimated to grow with a CAGR of 9.4% from 2020-2027. The report provides trends prevailing in the global biodefense market and the factors driving market along with those that act as hindrances.

Key Players Influencing the Market:

1.       Bavarian Nordic

2.       Alnylam Pharmaceuticals, Inc.

3.       SIGA Technologies

4.       Emergent BioSolutions Inc.

5.       Cleveland Bio Labs

6.       Dynavax Technologies

7.       Elusys Therapeutics, Inc.

8.       Soligenix

9.       Altimmune

10.   Pluristem Therapeutics

Get PDF Sample Copy of this Report @ https://bit.ly/2XLbtJk

The global biodefense market on the basis of product is segmented into anthrax, small pox, botulism, nuclear/radiation and others. In 2019, the anthrax segment accounted for the largest market share in the global biodefense market. The segment is expected to continue its dominance over the forecast period owing to increasing funding by the governments of other countries to develop and stockpile adequate vaccines against anthrax mainly through a variety of initiatives, such as BioShield Act, Biomedical Advanced Research and Development Authority (BARDA), and the Joint Program Executive Office for Chemical & Biological Defense. 

For instance, the US Department of Health and Human Services announced it would purchase an anthrax treatment for $25. Million from Elusys Therapeutics Inc., as a part of an emergency preparedness plan, in 2018.

The growth of the market is attributed to the some key driving factors such as presence of favorable government initiatives increase in the number of naturally occurring outbreaks, increasing threat of biological weapons and nuclear armed ICBM. However, low R&D funding by government in developing and underdeveloped economies are expected to restraint the growth of the market during the forecast years.

Reasons to Buy the Report :

Learn about the driving factors, affecting the market growth.

Imbibe the advancements and progress in the market during the forecast period.

Understand where the market opportunities lies.

Compare and evaluate various options affecting the market.

Pick up on the leading market players within the market.

Envision the restrictions and restrains that are likely to hamper the market.

[johnmartinhg-blog]

Next Generation Sequencing Market Set for Rapid Growth and Trend by 2027

According to The Insight Partners market research study titled Next Generation Sequencing Market to 2025 - Global Analysis and Forecasts by Product, Services, Applications, and End-Users, the global next generation sequencing market was valued at US$ 5,731.3 Mn in 2017 and is estimated to reach US$ 26,501.2 Mn by 2025. The report highlights the trends prevalent in the global next generation sequencing market and the factors driving the market along with those that act as deterrents to its growth.

The global next generation sequencing market is a matured market in the developing countries as well as developing economies worldwide. The necessity of genetic analysis is constantly increasing in recent days due to the reliable and accurate results being offered by the technique. The demand for next generation sequencing is experienced mostly from academic institutions followed by hospitals & clinics. Among the applications, the demand for next generation sequencing is significantly high in diagnostics, drug discovery, followed by precision medicine. Furthermore, advancements in sequencing technologies and declining cost of sequencing is expected to be a driving factor for the next generation market.

Get PDF Sample Copy of this Report @ https://bit.ly/2K6yTAW

Top Dominating Key Players:

1. Illumina, Inc.

2. Thermo Fisher Scientific, Inc.

3. Qiagen N.V.

4. Beijing Genomics Institute

5. Perkinelmer, Inc.

6. F. Hoffmann-La Roche AG

7. Agilent Technologies

8. Eurofins Scientific

9. Oxford Nanopore Technologies, Ltd.

10. Macrogen, Inc.

Modification and automation of this process continued to increase sequencing data and time reduction. Thereby allowing researchers to reach major milestones in the Human Genome Project. NGS makes sequence based gene expression analysis a "digital? alternative to analog techniques. It also aids in quantifying RNA expression with the breadth of a microarray and the resolution of qPCR. Advancement in genome sequencing has made the sequencing easy and accurate. These technological advancement are likely to grow the market in near future.

Cancer can be cured if diagnosed and treated at an initial stage. Cancer sequencing using next-generation sequencing (NGS) methods provides more information. Additionally, NGS also aids in diagnostics and treatment of cancer. In recent years, the cases of cancer has been increasing tremendously and the trend is anticipated to remain the same in the upcoming years. Due to preference of better technologies for detection of fatal disease, the demand for next generation sequencing is anticipated to witness constant growth in the upcoming years.

The market for next generation sequencing is well established in the region of North America, owing to the awareness regarding medical practices and technological developments in the process of next generation technology. Various market players have been focusing towards shifting their customer base in North America. For instance, Illumina, Inc. along with Telegraph, established a company called Verogen. The company would be entitled to provide Illumina's forensic products to the customers in the US.

Reasons to Buy the Report :

Learn about the driving factors, affecting the market growth.

 Imbibe the advancements and progress in the market during the forecast period.

Understand where the market opportunities lies.

Compare and evaluate various options affecting the market.

 Pick up on the leading market players within the market.

 Envision the restrictions and restrains that are likely to hamper the market.

[johnmartinhg-blog]

North America Clear Aligners Market Estimated to Flourish by 2027

The clear aligners market is growing primarily due to growing prevalence of dental problems, rising incidence of malocclusions in children, and increase in demand for dental cosmetic procedures. Restraining factors, such as high cost of clear aligners, are likely to damage the growth of the market in the coming years. On the other hand, rising dental tourism in the emerging nations is expected to have a positive impact on the growth of the North American in the coming years.

Rising incidence of malocclusions in children drive the market for clear aligners drugs. Malocclusion refers to a set of growth and developmental abnormalities that affect jaws and teeth, resulting in deviations in their position. People with several traits of malocclusion, including maxillary overjet, anterior irregularities, and anterior spacing, have a poor dental appearance and masticatory performance. But, patients need orthodontic treatment mostly because of disappointment with the look of their teeth rather than problems with oral functioning.

Register for a free Trial today and gain instant*access @ Click Here

Top Dominating Key Players:

1.    3M

2.    Danaher

3.    Dentsply Sirona

4.    Institut Straumann AG

5.    Henry Schein, Inc.

6.    Align Technology, Inc.

7.    Great Lakes Dental Technologies

8.    SCHEU DENTAL GmbH

9.    TP Orthodontics, Inc.

10. DynaFlex

The prevalence of malocclusion is more in children with autism spectrum disorder (ASD). Posterior crossbite, grown overjet, and adverse maxillary crowding were the most widely diagnosed malocclusion traits in children. As per prevalence, malocclusion is ranked third, after tooth decay and periodontal disease. The rising incidence of malocclusion in the country is among the critical factors for market growth.

Purchase for Report @ https://bit.ly/2VAYFlU

According to the data of Elsevier B.V., the prevalence of severe deep overbite was around 8% in the US, with the average overbite ranging from 36.5% to 39.2% in children between the age of 5 and 6 years. Moreover, in a study published in the National Center for Biotechnology Information (NCBI), analysis of occlusion on some groups of adolescents between the age of 12 and 18 years was performed. According to the study, more than 93% of the subjects confirmed some form of malocclusion. Thus, the rising incidence of malocclusions in children and teenagers in the region has led to increased use of invisible orthodontics, which thereby propels the market growth.

Key Benefits:

This report provides a detailed study of market trends and forecast from 2019 to 2025, which assist to identify the prevailing market opportunities.

In-depth coverage of the global market that includes drivers, restraints, and opportunities, helps professionals to understand the market behavior in a better way.

Detailed study of the strategies of key leaders, partnerships, and acquisitions in the market is provided.

Source : Business Market Insights

[johnmartinhg-blog]

Synthetic Biology Market New Report Projects Strong Growth for 2025

According to The Insight Partners market research study titled ‘Synthetic Biology Market  to 2025 – Global Analysis and Forecasts by Product, Technology and Application, the global synthetic biology market was valued at US$ 8,244.8 Mn in 2017 and is estimated to reach US$ 56,044.9 Mn by 2025. The report highlights the trends prevalent in the global synthetic biology market and the factors driving the market along with those that act as deterrents to its growth. The global synthetic biology market is a matured market in the developing countries as well as developing economies worldwide. Increasing number of start-up companies is a major driver for the growth of synthetic biology market. In the recent years, there has been a significant rise in the number of start-up companies in the US. Various government initiatives and funding programs for biotechnology enable the entrepreneurs of these start-ups to raise funds, equipment and space in respective regions.

Get PDF Sample Copy of this Report @ https://bit.ly/2VoFc7W

The List of Companies - Synthetic Biology Market

1. Thermo Fisher Scientific Inc. 2. Merck KGaA 3. Novozymes 4. Agilent Technologies 5. Amyris 6. GenScript 7. Integrated DNA Technologies, Inc. 8. Twist Bioscience 9. New England Biolabs 10. Synthetic Genomics Inc.

For instance Indie Bio, a synthetic biology accelerator program headquarter at California, US and Ireland offers funding and mentorship through its three-month training program. Moreover, the technological advancement has headed emergence of the New Bioeconomy, which is the replacement of petrochemical-based manufacturing and fermentation-based manufacturing products. In addition, the investments from public and private investors are rising for the synthetic biology. The rise in the investment are enabling technological developments and standard biological parts.

The market for synthetic biology is well established in the region of North America, owing to the investments made by the major companies and technological developments in the process of synthetic biology. Various market players have been focusing towards shifting their customer base in North America. For instance, the Government of Canada provides US$950 Mn for innovations to address the growing challenge of developing diverse and highly innovative economy. The development aimed to connect the businesses, academics, and policymakers, for the growth of several high-tech fields. So, this development of new clusters is one of the major factors for the development of domestic synthetic biology market of Canada.

What our report offers:

Learn about the driving factors, affecting the market  growth.

Imbibe the advancements and progress in the market during the forecast period.

Understand where the market opportunities lies.

Compare and evaluate various options affecting the market.

Pick up on the leading market players within the market.

Envision the restrictions and restrains that are likely to hamper the market.

[johnmartinhg-blog]

Irritable Bowel Syndrome Treatment Estimated to Flourish by 2027

The growth of the market is driven by the factors such as, increasing prevalence of irritable bowel syndrome and associated conditions, and increasing numbers of FDA approvals & drug developments. On the other hand, limited number of product availability and treatment inefficiency is likely to restraint the growth of market during the forecast years.

Irritable Bowel Syndrome is a majorly observed chronic gastrointestinal condition that is caused due to disturbances in bowel habits and abdominal pain. The disease is also known as spastic colon, irritable colon, mucous colitis, and spastic colitis. Irritable bowel syndrome shows symptoms such as abdominal pain, constipation, diarrhea, and cramping.

Register for a free Trial today and gain instant*access @ Click Here

Top Dominating Key Players:

1.     Ironwood Pharmaceuticals, Inc.

2.     Allergan Plc.

3.     Sebela Pharmaceuticals, Inc.

4.     Takeda Pharmaceutical Company Limited

5.     Alfasigma S.p.A.

6.     Astellas Pharma Inc.

7.     AstraZeneca

8.     Synthetic Biologics, Inc.

9.     Bausch + Lomb Incorporated

10. Lannett Company Inc.

Health systems across the regions are witnessing considerable growth in the incidence of irritable bowel syndrome. According to data published by International Foundation for Gastrointestinal Disorders, among all irritable bowel syndrome patients about 40% of people have mild IBS, around 35% have moderate IBS, and an estimated have 25% severe IBS. Many people don't recognize IBS symptoms. Certain factors such as food allergies, developing stages of gastroenteritis, sporadic movements of colon, abnormal composition of serotonin in colon, and mild celiac disease are some of the risk factors which are causing irritable bowel syndrome.

These factors are projected to accelerate the rate of prevalence of irritable bowel syndrome across the globe. For instance, according to a study published on NCBI in 2018, irritable bowel syndrome is estimated to affect around 10% to 16% of the US population each year. Such staggering prevalence of irritable bowel syndrome is likely to boost the US irritable bowel syndrome treatment market during the forecast period.

Purchase for Report @ https://bit.ly/2V8PsCz

Key Benefits:

This report provides a detailed study of market trends and forecast from 2019 to 2025, which assist to identify the prevailing market opportunities.

In-depth coverage of the global market that includes drivers, restraints, and opportunities, helps professionals to understand the market behavior in a better way.

Detailed study of the strategies of key leaders, partnerships, and acquisitions in the market is provided.

Source : Business Market Insights

[johnmartinhg-blog]

Menstrual Cups Market Growth, Size & Industry Forecast - 2027

The growth of the market is driven by factors such as the increasing popularity of menstrual cups, and infections due to sanitary pads and tampons in the North America region. Whereas, disadvantages of menstrual cups likely to have a negative impact on the growth of the market in the coming years. Menstrual cup is a hygiene product used by the female during menstruation. It is a best alternative for tampons and pads, and prevents leakage of blood onto the clothes. Menstrual cups are made of various material such as silicone, rubber, thermoplastic elastomer (TPE). The cups are worn internally near the vaginal canal where it collects the blood rather than absorbing it.

Register for a free Trial today and gain instant*access @ Click Here

Top Dominating Key Players:

Anigan Inc.

Diva International Inc.

Earth Care Solution

Lunette Menstrual Cup

Me Luna

Mooncup Ltd

Procter & Gamble

Silky Cup

The Keeper Inc.

YUUKI COMPANY S.R.O.

Menstruation is a part of women’s life; however, talking about it is difficult for some women. Recently with government initiatives and support, talking about menstruation is easier, and thus new products are being launched in the market. Tampon, menstrual pad, and liners are the most commonly used products, and the market players are also cutting down their prices in order to increase their sales. As per the charity Bloody Good Period, spent on period products in an average lifetime by a woman. Such organizations are eradicating the stigma surrounding menstruation by encouraging conversations on it. Menstrual cups are becoming more popular due to the growing preference for reusable products. The menstrual cups are inexpensive, reusable, and safe and are unlikely to leak like other products such as menstrual pads and tampons. The menstrual cup, which is made of flexible silicone, plastic, or latex and worn inside the vagina, collects blood instead of absorbing it, so it won’t get saturated. It can be worn for up to 12 hours and since it lasts for years, it’s much affordable and environmentally responsible. Social media platforms like Facebook and Instagram are promoting the adoption of menstrual cups. Therefore, the demand for menstrual cups is expected to increase during the forecast period.

Purchase for Report @ https://bit.ly/3ciJzZk The increasing use of menstrual cups as there is a shift towards using reusable products in North America is expected to drive menstrual cups market the growing in the country create a lucrative opportunity and the presence of an established market for menstrual cups.

Source : Business Market Insights

[johnmartinhg-blog]

Contract Research Organization (CRO) Market to Reflect Impressive Growth Rate by 2027

Pharmaceutical and biotech companies are focusing on the research and development (R&D) to come up with new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest majorly on the R&Ds with the aim of delivering high quality and innovative products to the market. R&D spending by the biopharmaceutical companies has also increased over the years.

Register for a free Trial today and gain instant*access @ https://bit.ly/3e4dRk6

According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$ 49.6 Bn 2012 to US$ 58.8 Bn in 2015. Research and development expenditures relate to the processes of discovering, testing and developing new products, upfront payments and milestones, improving existing products, as well as demonstrating product efficacy and regulatory compliance prior to launch. 

According to the International Federation of Pharmaceutical Manufacturers & Associations, the R&D expenditures in 2014 by the pharmaceuticals and biotechnology industry grew by approximately 8.7% than that of the expenditures in 2013. Top Dominating Key Players:

IQVIA

Laboratory Corporation of  America Holdings

PAREXEL International Corporation

ICON plc

Syneos Health

PRA Health Sciences

Charles River

Pharmaceutical Product Development, LLC

WuXi AppTec

Medpace

Moreover, in United States, investments for R&D by pharmaceutical companies had grown consistently over the last 15 years. The intensity for R&D by the companies in Japan accounted for about 13.3%, in US it accounted approximately 17% and in the European Union it was registered to be approximately 13% in the year 2014. Therefore, the pharmaceutical and biotech companies prefer to outsource the services to the contract research organizations (CROs) in order to save the cost and time which is expected to drive the growth of the market. US is expected to lead the market in the North America region owing to increasing expenditure of research and development expenditures in the country. The confrontation of biotechnology and pharmaceutical companies to lower the drug development costs is expected to propel the CROs market in the US. Moreover, the presence of top revenue generating pharmaceutical companies in the US that have capability to invest a large amount in R&D is also expected to boost the growth of CROs in the US. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period. Purchase for Report @ https://bit.ly/2JRWIfz Key Benefits:

This report provides a detailed study of market trends and forecast from 2019 to 2025, which assist to identify the prevailing market opportunities.

In-depth coverage of the global market that includes drivers, restraints, and opportunities, helps professionals to understand the market behavior in a better way.

Detailed study of the strategies of key leaders, partnerships, and acquisitions in the market is provided.

Source : Business Market Insights

[johnmartinhg-blog]

Cell Line Development Market Estimated to Flourish by 2027

The growth of the is driven by the factors such as increase in the demand for innovative products from biopharmaceutical and biotechnology companies, the presence of key market players, and extensive R&D conducted by various academic and research institutes in the North America region.

The medical biotechnology has undergone revolutions as a result of various development programs, business strategies that helps to produce, discover, or alter various biomolecules and organisms through bioengineering approaches. The Biotech Startup Revolution has also assisted in promoting the new ventures holding promising and innovative ideas in the country and supported in maximizing the revenue generation and thus the economic position of North America in the global cell line development market.

Register for a free Trial today and gain instant*access @ Click Here

Top Dominating Key Players:

Merck KGaA

Thermo Fisher Scientific, Inc.

Sartorius AG

SELEXIS

BioFactura, Inc.

WuXi AppTec

LakePharma, Inc.

General Electric Company

Lonza

Corning Incorporated

Moreover, increasing focus on advanced method incorporation in healthcare, government, and private initiatives for promotion of precision medicine and massive funds from government and private bodies for genomic research are further expected to stimulate growth and contribute to exceptional revenue generation for the cell line development market in North America.

US is anticipated to lead the adoptions of cell line development across the North American region through the forecast period. The increasing investments and rising funds dedicated to the manufacturing companies as well as academic and research institutes for the development of cell line based end products such as precision medicine and other therapeutics is one of the major driving factors. In 2018, The All of Us Research Program of NIH funded the Genome Centers in generating genotype sequence data from bio samples. These factors are expected to accelerate market growth over the forecast years.

Purchase for Report @ https://bit.ly/2xTQDwt

Key Benefits:

This report provides a detailed study of market trends and forecast from 2019 to 2025, which assist to identify the prevailing market opportunities.

In-depth coverage of the global market that includes drivers, restraints, and opportunities, helps professionals to understand the market behavior in a better way.

Detailed study of the strategies of key leaders, partnerships, and acquisitions in the market is provided.

Source : Business Market Insights

[johnmartinhg-blog]

Biodefense Market Foreseen to Grow Exponentially by 2027

Disease outbreaks are usually caused by an infection, transmitted through person-to-person contact, animal-to-person contact, or from the environment or other media. Emerging infectious diseases are infections that have recently appeared within a population and are rapidly increasing or threaten to grow shortly.

The World Health Organization warned in its 2007 report that infectious diseases are emerging at a rate that has not been seen before. Since the 1970s, about 40 infectious diseases have been discovered, including SARS, MERS, Ebola, avian flu, swine flu, zika, and most recently, coronavirus. Moreover, as per CDC estimates, between 2016 and 2017, nearly 30 Million people suffered from influenza in the U.S. Biodefense techniques, such as vaccinations against influenza; helps reduce the illness by 17% and medical visits and hospitalizations by 18 to 19% respectively.

Register for a free Trial today and gain instant*access @ Click Here

The growing prevalence of Ebola and Zika virus infections is also likely to contribute to the market development. For instance, due to coronavirus outbreak, more than 210,000 cases have now been reported to WHO, and more than 9,000 people have lost their lives as of 20 March 2020. Further, on March 18, 2020 Emergent BioSolutions signed development and manufacturing agreement with Vaxart for their experimental oral vaccine candidate for Coronavirus Disease.

Top Dominating Key Players:

Bavarian Nordic

Alnylam Pharmaceuticals, Inc.

SIGA Technologies

Emergent BioSolutions Inc.

Cleveland Bio Labs

Dynavax Technologies

Elusys Therapeutics, Inc.

Soligenix

Altimmune

Pluristem Therapeutics

The release of pathogenic agents such as anthrax or smallpox, biological toxins, chemical weapons such as nerve gas, or radioactive substances caused public threats in the past. In order to prevent such outbreaks, the government has planned various strategies, For instance, the NIH‐supported research on infectious diseases and biodefense builds and maintains a base of fundamental knowledge about contagious and immune‐related diseases and uses that knowledge to develop new and improved diagnostics, therapeutics, and preventive measures, including vaccines.

Purchase for Report @ https://bit.ly/3aMt9b8

Key Benefits:

This report provides a detailed study of market trends and forecast from 2019 to 2027, which assist to identify the prevailing market opportunities.

In-depth coverage of the global market that includes drivers, restraints, and opportunities, helps professionals to understand the market behavior in a better way.

Detailed study of the strategies of key leaders, partnerships, and acquisitions in the market is provided.

Source : Business Market Insights

[johnmartinhg-blog]

Better Opportunities for Oncology Biosimilars

Biosimilars are the fastest-growing class of therapeutic products across the globe. Biosimilars are biologics that serves as interchangeable products offering additional treatment options to a branded drug counterpart, potentially reducing the cost of the prescribed biologics.

The biosimilar therapies have been for chronic disease management and supportive care since a few years, however the use of these biosimilars are expected to be applied soon for treatment of various types of cancers referred to as oncology biosimilars.

Get PDF Sample Copy of this Report !!!

The market for oncology biosimilars market is expected to witness growth due to extensive research undertaken by market players to bring biosimilars for cancer treatment in the market as well as rapid approval by regulatory authorities for commercialization of these products. However, high costs involved in the research and complexity involved in the formulation of these biologics are likely to hinder market growth.

Top Leading Market Players:

1. Biocon 2. Celltrion Inc. 3. Dr. Reddy's Laboratories Ltd. 4. Amgen Inc. 5. Intas Pharmaceuticals Ltd. 6. Pfizer Inc. 7. Sandoz International GmbH (A Novartis Division) 8. Teva Pharmaceutical Industries Ltd. 9. Mylan N.V. 10. BIOCAD

The global oncology biosimilars market is segmented on the basis of product, cancer type, and distribution channel. On the basis of product, the global oncology biosimilars market is segmented into monoclonal antibodies, Immunomodulators, and others. On the basis of cancer type, the global oncology biosimilars market is segmented in to lung cancer, colorectal cancer, cervical cancer, breast cancer, kidney cancer, stomach cancer, brain cancer, and others. On the basis of distribution channel, the oncology biosimilars market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies.

Key Benefits :

• To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global Oncology Biosimilars Market.

• To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa).

Source : The Insight Partners

[johnmartinhg-blog]

Cash Logistics Industry Technological Innovation and Future Scope

Cash logistic means physical transfer of banknotes, coin from one place to another. It involves all the activities, such as collecting, handling, and transfer. The cash centers and bank branches, ATM points, large retailers, and others are holding large amounts of cash that to be transferred from one place to another; this drives the cash logistics market. The physical transfer of cash may not be taken lightly, and it gives more security for that purpose; it raises demand for the cash logistic market globally.

Get PDF Sample Copy of this Report @ Click Here

The services such as cash-in-transit, ATM services, cash management are rising demand for the cash logistic market. They are increasing cash demand for the emerging economies rising demand for the cash logistic market. However, the increase in digital transactions and cash-in-transit robberies restrain the growth of the market. Hike in a cash transaction, ATM services, banks, financial institution require enhanced security; hence, it demands cash logistics which create a lucrative opportunity for the market player of the cash logistics market.

Top Leading Market Players:

The Brink's Company

Cash Logistik Security AG

CMS Info Systems Ltd.

G4S plc.

Garda World Security Corporation

Global Security Logistics Co.

GSLS

Lemuir Group

Loomis AB

Prosegur Cash, S.A.

The Cash Logistics Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

The global cash logistics market is segmented on the basis of services, end-user. On the basis of services the market is segmented as cash-in-transit, ATM services, cash management. On the basis of end-user the market is segmented as retailers, government agencies, financial institution, others.

Download PDF Brochure @ Click Here

Do you need actual market size estimates for the Cash Logistics market?

Do you want to know the most attractive market segments in the Cash Logistics market?

Do you need technological insights into the Cash Logistics market?

Do you wish to benchmark your position in the global Cash Logistics market?

Do you need concrete data for making actionable business strategies?

[johnmartinhg-blog]

Top 10 Companies in Nano PLC Industry

A nano programmable logic controller (PLC) offer economical solutions to basic control needs for simple machines ranging from simple control timing and logic to relay replacement. Integrated I/O & communication, compact packaging and ease of usage make these controllers an ideal choice for applications such as security systems, conveyor automation, building and parking lot lighting and others.

The nano PLC perform functions such as data gathering, monitoring devices, supervisory control and various other process parameters of programs through communicating with other computer equipment or controllers.

GET PDF SAMPLE COPY @ CLICK HERE

The nano PLC market is anticipated to grow owing to driving factors such as the growing home automation market, rising demand for compact automation and increase in adoption of IoT in various industries. However, the huge capital investment involved in installation of nano PLC is expected to hinder the market growth.

Top Dominating Key Players:

1. Crouzet Automatismes 2. EZAutomation Australia Pty Ltd. (AVG Automation) 3. General Electric 4. IDEC Corporation 5. KEYENCE CORPORATION 6. Mitsubishi Electric Corporation 7. Omron Corporation 8. Rockwell Automation Inc. 9. Schneider Electric 10. Siemens AG

The global Nano PLC market is segmented on the basis of type, component and industry vertical. Based on type, the market is segmented as fixed nano PLC and modular nano PLCs. Further, based on component, the market is divided into hardware and software. Hardware is further sub segmented by processor, power supply, input/output (I/O) and others. Furthermore, on basis of industry vertical, market is segmented as energy & power, automotive, oil & gas, pharmaceutical, metals & mining and others.

Download PDF Brochure @ http://bit.ly/2VP2qTK

The Nano PLC Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

[johnmartinhg-blog]

Scissor Lift Market Insights Growth Opportunities and Forecast to 2025

According to the new research report published by The Insight Partners, titled “Scissor Lift Market - Global Analysis and Forecast to 2025”, the global scissor lift market is expected to reach US$ 3,682.1 million in 2025, registering a CAGR of 4.3% during the forecast period 2018-2025.  

The scissor lift market has experienced significant growth and adoption rate in the past few years and is expected to experience notable growth and adoption in years to come. One of the major reason for surged adoption of scissor lift is the rapidly increasing investment in construction and infrastructural development. The world is known to witness a dramatic increase in its urban population creating pressure on the construction industries to come up with a robust plan of action. Owing to this pressure the construction machinery manufacturers are encouraged to focus upon the development and updation of their present product lines. In the coming years, scissor lifts are projected to perform various tasks that comply with the forthcoming demands of the end users.

Top Dominating Key Players:

Terex Corporation

JLG industries

Aichi Corporation

Haulotte Group

Linamar Corporation

MEC Aerial Work Platforms

Galmon (S) PTE. Ltd.

Wiese, Inc

Edmolift AB

Advance Lifts Inc.

These changes comprise of enhanced safety and maximizing capacity. The Scissor lifts are inherently safer and more practical than ladders. Also, these machine/equipment are considered as much more economical than various other powered lifting equipment, and thus they are among the frequently invested machinery in industries, especially construction and manufacturing. While investing in scissor lifts, there are myriad aspects that the investor looks upon. Safety, productivity, and efficiency are some of the critical elements of them.

The global scissor lift market has been segmented based on movement type, i.e., mobile scissor lift and fixed scissor lift. The mobile scissor lifts have widely gained popularity owing to their ability to accommodating the flexible production lines. Further, the mobile lifts are demanded more in the applications involving mobility within the space and transportation of loads where the assembly lines are required to be frequently reconfigured.

Key findings of the study:

Europe is anticipated to account the largest market share of the scissor lift market and is expected to register a CAGR of 4.3%

Based on the movement type, the mobile scissor lift segment is expected to witness high year on year growth during the forecast period

Countries such as China, Brazil, and India are witnessing high demand for scissor lift due to the increasing construction activities and government projects.

Asia-Pacific holds the second largest market share.  The large role played by the governments of different countries based in the APAC region for supporting the infrastructure development is positively impacting the market. Further, the Building and Construction Authority (BCA) of Singapore expects that the construction projects in Singapore during the year 2018 has reached around US$ 26.31 Bn. The constant development and rising need for housing in the region are further expected to influence the scissor lift equipment market during the forecast period.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

The Insight partners,

Phone: +1-646-491-9876 Email: sales@theinsightpartners.com